Research
For the series finale, Peter Lee, Carey Goldberg, and Dr. Zak Kohane compare their predictions to insights from the series’ most recent guests, including experts on AI’s economic and societal impact, leaders in AI-driven medicine, and doctors in training.
Former Washington State Secretary of Health Dr. Umair Shah and Mayo Clinic CEO Dr. Gianrico Farrugia explore how healthcare leaders are approaching AI when it comes to public health, care delivery, the healthcare-research connection, and the patient experience.
Next-generation physicians Morgan Cheatham and Daniel Chen discuss how generative AI is transforming medical education, exploring how students and attending physicians integrate new tools while navigating questions on trust, training, and responsibility.
Daphne Koller, Noubar Afeyan, and Dr. Eric Topol, leaders in AI-driven medicine, discuss how AI is changing biomedical research and discovery, from accelerating drug target identification and biotech R&D to helping pursue the “holy grail” of a virtual cell.
Bioethics and law expert R. Alta Charo explores the value of regulating technologies at the application level and the role of coordinated oversight in genome editing, while Microsoft GM Daniel Kluttz reflects on Charo’s points, drawing parallels to AI governance.
Technologists Bill Gates and Sébastien Bubeck discuss the state of generative AI in medicine, how access to “medical intelligence” might help empower people across healthcare, and how AI’s accelerating improvements are likely to affect both delivery and discovery.
Ethan Mollick and Azeem Azhar, thought leaders at the forefront of AI’s influence on work, education, and society, discuss the impact of AI at the individual level and what that means for the healthcare workforce and the organizations and systems in medicine.
In this discussion, Matthew Lungren, Jonathan Carlson, Smitha Saligrama, Will Guyman, and Cameron Runde explore how teams across Microsoft are working together to generate advanced AI capabilities and solutions for developers and clinicians around the globe.
Peter Lee and his coauthors, Carey Goldberg and Dr. Zak Kohane, reflect on how generative AI is unfolding in real-world healthcare, drawing on earlier guest conversations to examine what’s working, what’s not, and what questions still remain.
Healthcare experts Laura Adams, Vardit Ravitsky, and Dr. Roxana Daneshjou discuss responsible AI implementation in medicine, examining governance approaches, shifting patient-provider relationships, and the identification of bias to ensure equitable deployment.
Evangelist for patient empowerment Dave deBronkart and Manatt Heath’s Christina Farr discuss how generative AI is redefining healthcare by empowering patients, challenging traditional care models, and creating new opportunities for innovation and collaboration.
Microsoft’s Dr. Matthew Lungren and Epic’s Seth Hain discuss the challenges and opportunities of leveraging generative AI for enhanced patient care and improved clinical documentation and recordkeeping at scale—plus what’s next for the technology in the field.